Exercise As A Mechanism to Increase Per2 Expression in Type 2 Diabetics
Kacie Mitchell
Introduction: Type 2 diabetes (T2D) is a highly prevalent metabolic disease characterized by insulin resistance.1 In 2015, it was estimated that 1 in 11 adults aged 20-79 were diagnosed with diabetes and over 90% of those were type 2.1 Underlying causes of T2D include obesity, caloric excess, and sedentary lifestyles.1 Behaviors such as smoking and alcohol intake are also associated with increased risk of T2D.1 Recent studies have identified a link between T2D and circadian rhythm disruptions.2 The circadian rhythm is the endogenous 24 hour cycle that is governed by a central clock in the hypothalamus.3 The central clock controls peripheral clocks in tissues such as skeletal muscle through proteins like Per2.3 Period circadian regulator 2 (Per2) is expressed in skeletal muscle and controls oscillations in glucose-handling genes in insulin-dependent tissues.4 A recent study found that Per2 was significantly decreased in mononuclear cells of T2D patients.5 Exercise has been known to ameliorate T2D pathogenesis.1 Exercise modifies circadian clocks in skeletal muscle through increased expression of Per2 through hypoxic and contractile-mediated mechanisms.4,5,6 Methods: C2C12 myotubes were isolated from rodents and treated with an HIF1a stabilizing agent to mimic hypoxia during exercise.6 Chromatin immunoprecipitation of HIF1a was performed at enhancer boxes of the Per2 promoter.6 C2C12 myotubes were isolated and treated with electrical pulsatile stimulation (EPS) to mimic exercise.4 Following the EPS treatment, Per2 expression was measured.4 Myotubes were also treated with ionomycin (calcium ionophore) and nifedipine (calcium channel blocker).4 After this treatment and EPS, Per2 expression was measured.4 To determine the mechanism of Per2 upregulation, levels of ubiquitous transcription factor CREB were measured and compared to its active phosphorylated form (pCREB.)4 Levels of pCREB were measured following EPS and treatment with ionomycin or nifedipine.4 Results: Stabilization of HIF1a led to increased levels and duration of Per2 expression.6 Additionally, HIF1a was bound to the enhancer box of the Per2 promoter.6 Per2 expression was increased by 1.5 fold 60 minutes following EPS treatment.4 Treatment with ionomycin increased Per2 expression, while treatment with nifedipine decreased Per2 expression both before and following EPS.4 EPS and ionomycin treatment increased the levels of pCREB significantly while EPS and nifedipine treatment decreased pCREB expression.4 Conclusions: These results demonstrate that Per2 expression is increased during exercise through upregulation by HIF1a.6 Additionally, these results identify a contractile-mediated mechanism of Per2 upregulation that is calcium-dependent.4 Specifically, Per2 expression is increased through calcium-dependent phosphorylation of CREB and subsequent Per2 expression.4
- Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88-98. doi:10.1038/nrendo.2017.151
- Mason IC, Qian J, Adler GK, Scheer FAJL. Impact of circadian disruption on glucose metabolism: implications for type 2 diabetes. Diabetologia. 2020;63(3):462-472. doi:10.1007/s00125-019-05059-6
- Onaolapo AY, Onaolapo OJ. Circadian dysrhythmia-linked diabetes mellitus: Examining melatonin’s roles in prophylaxis and management. World J Diabetes. 2018;9(7):99-114. doi:10.4239/wjd.v9.i7.99
- Small L, Altıntaş A, Laker RC, et al. Contraction influences Per2 gene expression in skeletal muscle through a calcium-dependent pathway. J Physiol. 2020;598(24):5739-5752. doi:10.1113/JP280428
- López-Cano C, Gutiérrez-Carrasquilla L, Barbé F, et al. Effect of Type 2 Diabetes Mellitus on the Hypoxia-Inducible Factor 1-Alpha Expression. Is There a Relationship with the Clock Genes?. J Clin Med. 2020;9(8):2632. Published 2020 Aug 13. doi:10.3390/jcm9082632
- Peek CB, Levine DC, Cedernaes J, et al. Circadian Clock Interaction with HIF1α Mediates Oxygenic Metabolism and Anaerobic Glycolysis in Skeletal Muscle. Cell Metab. 2017;25(1):86-92. doi:10.1016/j.cmet.2016.09.010